Davis Research Group Announces Publication of Research Report on American CryoStem
TEANECK, N.J., Nov. 19, 2012 (GLOBE NEWSWIRE) — Davis Research Group, a leader in covering emerging microcap companies, is pleased to announce its research report on American CryoStem Corporation (OTCQB:CRYO). American CryoStem is a biotech company in the regenerative medicine industry participating in the rapidly expanding adult stem cell market.
The report can be viewed here.
This research report covers the Regenerative Medicine industry and highlights American CryoStem’s patented adult stem cell technologies as a leading biotech company commercializing its products and services. “We are pleased with the report and share the same excitement with David Research Group about our patented stem cell technologies. We are eager to begin offering our newly developed fat storage platform and continue our efforts towards our stem cell based wound healing project,” commented Anthony Dudzinski, COO of American CryoStem Corporation.
About Davis Research Group: Davis Research Group is affiliated with Davis Family Investments which was formed as Davis and Co. as a holding company in 1857. Specializing in microcap type investments, Davis Research Group manages certain databases which include thousands of various money managers, venture capital and hedge funds which specialize in growth plus emerging companies. Select information reports are published by Davis Research Group which highlight companies’ operational results along with growth prospects which are distributed on the internet through various managed databases.
About American CryoStem: American CryoStem Corporation (OTCQB:CRYO) is a leading biotech company focused on marketing its clinical processing services and patented products for adipose (fat) tissue and adipose derived adult stem cells. Our clinical tissue processing, patented cell culture media products and tissue storage platform supports cosmetic and regenerative medicine applications being developed globally. The Company provides high quality, clinically processed viable cells, while at the same time developing cutting edge applications, therapies, patented laboratory products and services for consumer and commercial applications.
Davis Research Group
751 Palisades Ave., Drawer 2083
Teaneck, NJ 07666